@Biopharma_Watch BiopharmaWatch

BiopharmaWatch posts on X about catalyst, $ptpi, $ocea, market the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

[--] Week [------] +42%
[--] Month [------] +75%
[--] Months [-------] +48%
[--] Year [-------] +128%

Mentions: [--] #

[--] Week [---] +15%
[--] Month [---] +37%
[--] Months [-----] +87%
[--] Year [-----] +2,357%

Followers: [-----] #

[--] Week [-----] +1.60%
[--] Month [-----] +6.20%
[--] Months [-----] +36%
[--] Year [-----] +130%

CreatorRank: [---------] #

Social Influence

Social category influence stocks 48.13% cryptocurrencies 9.38% finance 3.75% exchanges 3.13% technology brands 3.13% travel destinations 0.63% financial services 0.63% currencies 0.63%

Social topic influence catalyst #110, $ptpi #3, $ocea #5, market 5.63%, $eton #1, eton #26, $pthl 5%, $tnfa 5%, $ocul #36, $inab 4.38%

Top accounts mentioned or mentioned by @monacobiotech @maximusholla @boudin420

Top assets mentioned Ocular Therapeutix, Inc. (OCUL) IN8bio, Inc. (INAB) Taraxa (TARA) Biofrontera Inc. (BFRI) Inspira Technologies OXY B.H.N. Ltd (IINN) Maze Therapeutics, Inc. (MAZE) Picard Medical, Inc. (PMI) Tenaya Therapeutics, Inc. (TNYA) Gilead Sciences, Inc. (GILD) Adagene Inc. (ADAG) Stader BNBx (BNBX) Pharming Group N.V. (PHAR) Elevai Labs, Inc. (ELAB) HCW Biologics Inc. (HCWB) Heart Test Laboratories Inc. (HSCS) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Relay Therapeutics, Inc. (RLAY) Alumis Inc. (ALMS) Nurix Therapeutics, Inc. (NRIX) Centessa Pharmaceuticals plc (CNTA) Immunocore Holdings Limited (IMCR) ArriVent BioPharma, Inc. (AVBP) Arvinas, Inc (ARVN) Bruker, Corp. (BRKR) Audiera (BEAT) Sanofi (SNY) Denali Therapeutics Inc. Common Stock (DNLI) Travere Therapeutics, Inc. Common Stock (TVTX) MapLight Therapeutics, Inc (MPLT) PolyPid Ltd. (PYPD) Alvotech Ordinary Shares (ALVO) Twist Bioscience Corporation Common Stock (TWST) apM Coin (APM) Olema Pharmaceuticals, Inc. (OLMA) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) CheckDot (CDT)

Top Social Posts

Top posts by engagements in the last [--] hours

"Our latest release from the Oncology [--] portfolio has delivered impressive results achieving a 4.78% last month and a remarkable annual return of 98.46% 🚀 Open to feedback ✌ $NRIX $CNTA $SNDX $GLPG $IMCR $BCYC $XNCR $KURA $AVBP $CSTL"
X Link 2024-11-12T17:14Z [----] followers, [----] engagements

"$ARVN 7.42$ 7.23% June [--] [----] Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader ARV-393 at the [----] European Hematology Association (EHA) Annual Meeting"
X Link 2025-06-06T15:45Z [----] followers, [---] engagements

"$TNXP 39.85$ -5.93% July [--] [----] Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025"
X Link 2025-07-11T15:45Z [----] followers, [---] engagements

"Top Market Movers: Negative News Full Access: $BRKR 29.35$ -11.68% September [--] [----] Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2025-09-04T13:38Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $BEAT - 409.7K - 9.9M - [-----] $OSRH - 7.1M - 138.6M - [-----] $ADAG - 178.5K - 3.3M - [-----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2025-11-24T15:45Z [----] followers, [---] engagements

"$TNYA 0.77$ -3.52% 2025-12-12T05:16:00.000Z Tenaya Therapeutics Announces Pricing of Public Offering"
X Link 2025-12-16T15:45Z [----] followers, [---] engagements

"$TNYA 0.77$ -3.52% 2025-12-11T21:02:00.000Z Tenaya Therapeutics Announces Proposed Public Offering"
X Link 2025-12-16T15:45Z [----] followers, [---] engagements

"Top Market Movers: Positive News Full Access: $DVAX 15.43$ 38.59% 2025-12-24T06:23:00.000Z Sanofi to Acquire Dynavax Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2025-12-24T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $BFRI - 262.9K - 4.8M - [-----] $BNBX - 127.2K - 2.1M - [-----] $IRWD - 4.0M - 53.8M - [-----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-01-02T15:45Z [----] followers, [---] engagements

"Latest catalysts: $DNLI Catalyst Date - 2026-04-05 Drug - tividenofusp alfa (DNL310) Treatment - Hunter syndrome (mucopolysaccharidoses type II MPS II) https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-01-05T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $ATLN - 217.3K - 5.4M - [-----] $BNBX - 184.0K - 3.8M - [-----] $BFRI - 303.1K - 6.0M - [-----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-01-05T15:45Z [----] followers, [---] engagements

"Latest catalysts: $ZYME Catalyst Date - 2026-01-08 Drug - Ziihera (zanidatamab-hrii) Treatment - HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-01-08T15:45Z [----] followers, [---] engagements

"Latest catalysts: $TVTX Catalyst Date - 2026-01-13 Drug - FILSPARI (sparsentan) Treatment - Focal Segmental Glomerulosclerosis (FSGS) https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-01-13T05:43Z [----] followers, [---] engagements

"$MPLT 19.07$ 5.83% 2026-01-09T12:00:00.000Z MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase [--] Studies to Q3 2026"
X Link 2026-01-13T05:44Z [----] followers, [---] engagements

"Top Market Movers: Negative News Full Access: $LPCN 10.14$ -8.89% 2026-01-20T13:00:00.000Z Lipocine Announces Completion of Enrollment and Dosing in Phase [--] Trial of LPCN [----] in Postpartum Depression (PPD) https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-01-20T15:45Z [----] followers, [---] engagements

"Latest catalysts: $PALI Catalyst Date - 2026-01-23 Drug - PALI-2108 (Colon-Targeted PDE4B Inhibitor) Treatment - Ulcerative Colitis https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-01-23T15:45Z [----] followers, [---] engagements

"$ADAG 2.17$ 7.14% 2026-01-23T13:00:00.000Z Adagene Provides Business Update and [----] Objectives"
X Link 2026-01-23T15:45Z [----] followers, [--] engagements

"Latest catalysts: $KOD Catalyst Date - 2026-01-31 Drug - Tarcocimab tedromer Treatment - Diabetic Retinopathy Poa : 80% https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-01-26T15:45Z [----] followers, [---] engagements

"Highest Volume Ticker - Price - Volume $PTPI - 0.07$ - 266.5M $OCEA - 0.02$ - 171.4M $PTHL - 0.90$ - 74.9M $TNFA - 5.20$ - 60.7M $WINT - 0.11$ - 56.0M https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-01-26T15:45Z [----] followers, [---] engagements

"$PYPD 4.61$ -3.87% 2026-01-28T13:00:00.000Z PolyPid to Report Fourth Quarter [----] Financial Results and Operational Highlights on February [--] 2026"
X Link 2026-01-28T15:45Z [----] followers, [---] engagements

"Top Market Movers: Positive News Full Access: $ALVO 5.50$ 3.88% 2026-01-29T08:00:00.000Z Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea 2mg https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-01-29T15:45Z [----] followers, [---] engagements

"Highest Volume Ticker - Price - Volume $PTPI - 0.07$ - 266.5M $OCEA - 0.02$ - 171.4M $PTHL - 0.90$ - 74.9M $FEED - 4.13$ - 68.1M $TNFA - 5.20$ - 60.7M https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-01-29T15:45Z [----] followers, [--] engagements

"$IINN 0.80$ 2.47% 2026-01-29T13:30:00.000Z ART100 Becomes Inspiras First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center"
X Link 2026-01-29T15:45Z [----] followers, [---] engagements

"$PHAR Catalyst Date - 2026-01-31 Drug - Leniolisib (oral selective phosphoinositide 3-kinase delta inhibitor) Treatment - Activated phosphoinositide 3-kinase delta syndrome (APDS) Poa : 85% https://www.biopharmawatch.com/company/PHAR https://www.biopharmawatch.com/company/PHAR"
X Link 2026-01-30T15:45Z [----] followers, [---] engagements

"Top Market Movers: Positive News Full Access: $TWST 46.62$ 13.51% 2026-02-02T12:15:00.000Z Twist Bioscience Announces Fiscal [----] First Quarter Financial Results https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-02T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $SXTC - 43.0M - 502.3M - [-----] $APM - 63.3K - 302.9K - [----] $AQST - 6.0M - 27.2M - [----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-02T15:45Z [----] followers, [---] engagements

"$OLMA 23.51$ -8.59% 2026-02-02T05:00:00.000Z Olema Oncology Announces Departure of Chief Operating and Financial Officer"
X Link 2026-02-02T15:45Z [----] followers, [--] engagements

"$RGNX Catalyst Date - 2026-02-08 Drug - RGX-121 Treatment - MPS II (Hunter syndrome) Poa : 0% https://www.biopharmawatch.com/company/RGNX https://www.biopharmawatch.com/company/RGNX"
X Link 2026-02-02T15:45Z [----] followers, [---] engagements

"$MLTX 16.45$ 4.98% 2026-02-02T13:00:00.000Z MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day"
X Link 2026-02-02T15:45Z [----] followers, [---] engagements

"Top Market Movers: Negative News Full Access: $BCYC 6.00$ -7.55% 2026-02-03T12:00:00.000Z Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-03T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $CDT - 714.8K - 14.3M - [-----] $LIMN - 712.9K - 13.0M - [-----] $ELAB - 778.3K - 6.8M - [----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-03T15:45Z [----] followers, [----] engagements

"$CMND 1.38$ 6.15% 2026-02-03T13:00:00.000Z Excellent Achievements for Clearminds Proprietary MEAI that was Included in U.S. Congress Emerging Therapies Bill to Expand Veteran Access to Innovative Treatments"
X Link 2026-02-03T15:45Z [----] followers, [--] engagements

"Top Market Movers: Positive News Full Access: $ONCY 1.01$ 15.63% 2026-02-04T13:50:00.000Z Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-04T15:45Z [----] followers, [---] engagements

"Top Market Movers: Negative News Full Access: $HYPD 3.67$ -9.61% 2026-02-04T13:00:00.000Z Hyperion DeFi Announces Institutional Volatility Income Vault Built on Rysk Protocol https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-04T15:45Z [----] followers, [---] engagements

"$INAB Catalyst Date - 2026-02-12 Drug - DeltEx Drug Resistant Immunotherapy (DRI) Treatment - Newly diagnosed glioblastoma Poa : 18% https://www.biopharmawatch.com/company/INAB https://www.biopharmawatch.com/company/INAB"
X Link 2026-02-04T15:45Z [----] followers, [--] engagements

"$ABBV 210.16$ -6.87% 2026-02-04T12:48:00.000Z AbbVie Reports Full-Year and Fourth-Quarter [----] Financial Results"
X Link 2026-02-04T15:45Z [----] followers, [--] engagements

"Top Market Movers: Positive News Full Access: $AIM 1.41$ 33.84% 2026-02-05T13:40:00.000Z AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase [--] Study Evaluating Ampligen (rintatolimod) in Combinatio https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-05T15:45Z [----] followers, [---] engagements

"$LBRX 24.59$ 16.15% 2026-02-05T13:00:00.000Z LB Pharmaceuticals Announces $100.0 Million Private Placement"
X Link 2026-02-05T15:45Z [----] followers, [--] engagements

"Highest Volume Ticker - Price - Volume $PTPI - 0.07$ - 266.5M $OCEA - 0.02$ - 171.4M $PTHL - 0.90$ - 74.9M $TNFA - 5.20$ - 60.7M $AIM - 1.41$ - 56.2M https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-05T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $GDTC - 372.2K - 10.2M - [-----] $EVGN - 471.7K - 12.8M - [-----] $XRTX - 132.0K - 2.7M - [-----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-05T15:45Z [----] followers, [---] engagements

"$IINN 0.66$ -5.32% 2026-02-05T13:00:00.000Z Inspira Announces Pricing of $4.75 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules"
X Link 2026-02-05T15:45Z [----] followers, [---] engagements

"Top Market Movers: Positive News Full Access: $CMND 1.38$ 6.15% 2026-02-06T12:55:00.000Z Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplas https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-06T15:45Z [----] followers, [---] engagements

"Top Market Movers: Negative News Full Access: $ERNA 0.36$ -47.34% 2026-02-06T14:25:00.000Z Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-06T15:45Z [----] followers, [---] engagements

"Latest catalysts: $BLTE Catalyst Date - 2026-02-06 Drug - Tinlarebant (a/k/a LBS-008) Treatment - Stargardt disease type [--] (STGD1) Poa : 45% https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-02-06T15:45Z [----] followers, [---] engagements

"$ANEB 0.53$ -35.06% 2026-02-06T14:00:00.000Z Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC"
X Link 2026-02-06T15:45Z [----] followers, [--] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $AIM - 2.4M - 68.5M - [-----] $RNAZ - 494.2K - 11.7M - [-----] $MBIO - 304.7K - 6.8M - [-----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-06T15:45Z [----] followers, [---] engagements

"$RNAZ 8.70$ -12.74% 2026-02-05T13:04:00.000Z TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138"
X Link 2026-02-06T15:45Z [----] followers, [--] engagements

"$KURA 7.67$ 3.65% 2026-02-06T12:30:00.000Z Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"
X Link 2026-02-06T15:45Z [----] followers, [---] engagements

"$MAZE Catalyst Date - 2026-02-11 Drug - MZE829 (dual-mechanism APOL1 inhibitor) Treatment - APOL1-mediated kidney disease (AMKD) Poa : 15% https://www.biopharmawatch.com/company/MAZE https://www.biopharmawatch.com/company/MAZE"
X Link 2026-02-06T15:45Z [----] followers, [--] engagements

"$QURE 25.36$ 3.45% 2026-02-06T12:05:00.000Z uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in -Gal A Enzyme Activity in Patients with Fabry Disease"
X Link 2026-02-06T15:45Z [----] followers, [---] engagements

"Top Market Movers: Positive News Full Access: $HUMA 1.17$ 24.28% 2026-02-09T13:00:00.000Z Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-09T15:45Z [----] followers, [---] engagements

"Top Market Movers: Negative News Full Access: $BFRI 0.74$ -9.85% 2026-02-09T14:15:00.000Z Biofrontera Announces Positive Results in Phase [--] Study of Ameluz PDT for Actinic Keratoses on the Extremities Neck and Trunk Meet https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-09T15:45Z [----] followers, [---] engagements

"$CMND 1.38$ 6.15% 2026-02-09T13:17:00.000Z Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial"
X Link 2026-02-09T15:45Z [----] followers, [--] engagements

"$IINN 0.68$ -5.30% 2026-02-09T12:00:00.000Z Inspira Secures Vendor Approval from $12 Billion Revenue HMO (Worlds 2nd Largest) Enabling Immediate ART100 Deployment"
X Link 2026-02-09T15:45Z [----] followers, [--] engagements

"$OCUL Catalyst Date - 2026-02-25 Drug - AXPAXLI (also known as OTX-TKI) Treatment - wet age-related macular degeneration (wet AMD) Poa : 55% https://www.biopharmawatch.com/company/OCUL https://www.biopharmawatch.com/company/OCUL"
X Link 2026-02-09T15:45Z [----] followers, [---] engagements

"$TARA Catalyst Date - 2026-02-27 Drug - TARA-002 Treatment - non-muscle invasive bladder cancer (NMIBC) Poa : 18% https://www.biopharmawatch.com/company/TARA https://www.biopharmawatch.com/company/TARA"
X Link 2026-02-09T15:45Z [----] followers, [---] engagements

"🚨BIOTECH ALERT: Our HF High-Vol Small/Midcap portfolio at BiopharmaWatch crushed it with 155.5% total return & 111.5% CAGR from Q2 [----] Turned $1M into $2.56M. Revealing Q2 [----] holdings NOW high-beta plays selected by volatility & hedge fund conviction. But Q3 [----] is NEXT LEVEL - Thread 🧵 https://www.biopharmawatch.com/bpw-portfolio https://www.biopharmawatch.com/bpw-portfolio"
X Link 2026-02-09T20:52Z [----] followers, [---] engagements

"Now let's break down the Q2 [----] holdings. Each position is equally weighted at 5% promoting diversification in this volatile sector. We've included key metrics like our proprietary score fund count (indicating hedge fund interest) HF quartile ranking and forward returns for context. These are high-conviction picks many with fund counts in the double digits. https://twitter.com/i/web/status/2020963992072511743 https://twitter.com/i/web/status/2020963992072511743"
X Link 2026-02-09T20:52Z [----] followers, [--] engagements

"Upcoming biotech Phase [--] catalysts to watch: $OCUL $OCGN $ANNX $IMMP $BCRX $ALT $ATYR $SLXN $PLRX $MBRX $BIOF Heres the full version: https://www.biopharmawatch.com/fda-calendar https://www.biopharmawatch.com/fda-calendar"
X Link 2026-02-09T22:02Z [----] followers, [---] engagements

"Top Market Movers: Positive News Full Access: $FBLG 0.27$ 8.19% 2026-02-10T13:30:00.000Z FibroBiologics Chairman & CEO Pete OHeeron Selected to Present at A4LIs H-SPAN Summit at Georgetown University https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-10T15:45Z [----] followers, [---] engagements

"Top Market Movers: Negative News Full Access: $BRTX 0.72$ -31.11% 2026-02-10T13:00:00.000Z BioRestorative Completes Patient Enrollment in Landmark Phase [--] Trial of BRTX-100 for Chronic Lumbar Disc Disease https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-10T15:45Z [----] followers, [---] engagements

"Highest Volume Ticker - Price - Volume $BONS - 0.00$ - $AIMD - 3.98$ - $RAIN - 7.30$ - $ACOG - 5.00$ - $QNCX - 0.30$ - 484.9M https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-10T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $IINN - 986.9K - 24.2M - [-----] $ENSC - 407.0K - 8.1M - [-----] $BFRI - 791.5K - 13.9M - [-----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-10T15:45Z [----] followers, [---] engagements

"$IQV 186.76$ -3.06% 2026-02-10T13:00:00.000Z IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions"
X Link 2026-02-10T15:45Z [----] followers, [--] engagements

"$ENLV 1.12$ -2.61% 2026-02-10T13:00:00.000Z Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken the Second-Largest U.S. Cryptocurrency Exchange"
X Link 2026-02-10T15:45Z [----] followers, [--] engagements

"$GELS 0.75$ -6.80% 2026-02-11T13:45:00.000Z Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership"
X Link 2026-02-11T15:45Z [----] followers, [--] engagements

"$BFRI 0.73$ -6.41% 2026-02-11T14:15:00.000Z Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz PDT in Superficial Basal Cell Carcinoma"
X Link 2026-02-11T15:45Z [----] followers, [--] engagements

"$GILD 156.07$ 6.01% 2026-02-11T05:00:00.000Z Gilead Sciences Announces [---] Percent Increase in First Quarter [----] Dividend"
X Link 2026-02-11T15:45Z [----] followers, [--] engagements

"$GILD 156.07$ 6.01% 2026-02-11T00:00:00.000Z Gilead To Stay Proactive And Disciplined With Deals But M&A Not Urgent Priority"
X Link 2026-02-11T15:45Z [----] followers, [--] engagements

"Top Market Movers: Negative News Full Access: $ONCO 1.16$ -37.57% 2026-02-12T13:00:00.000Z Onconetix to Acquire Realbotix LLC USA-based AI-Powered Humanoid Robotics Company https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-12T15:45Z [----] followers, [---] engagements

"$VRCA 5.54$ -2.72% 2026-02-12T13:00:00.000Z Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer"
X Link 2026-02-12T15:45Z [----] followers, [--] engagements

"$ANVS 2.64$ 11.35% 2026-02-12T13:00:00.000Z Annovis Secures DSMB Approval to Advance Pivotal Phase [--] Trial of Buntanetapin Alzheimers Disease"
X Link 2026-02-12T15:45Z [----] followers, [--] engagements

"$HCWB 0.75$ -8.88% 2026-02-13T13:30:00.000Z HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune"
X Link 2026-02-13T15:45Z [----] followers, [--] engagements

"Top Market Movers: Positive News Full Access: $PRLD 2.34$ 15.27% 2026-02-03T14:00:00.000Z Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396 a Mutant-selective JAK2V617F I https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-03T15:45Z [----] followers, [---] engagements

"Latest catalysts: $NERV Catalyst Date - 2026-02-03 Drug - roluperidone Treatment - negative symptoms of schizophrenia Poa : 25% https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-02-03T15:45Z [----] followers, [---] engagements

"$ETON Catalyst Date - 2026-02-25 Drug - ET-600 (desmopressin oral solution) Treatment - central diabetes insipidus Poa : 85% https://www.biopharmawatch.com/company/ETON https://www.biopharmawatch.com/company/ETON"
X Link 2026-02-04T15:45Z [----] followers, [---] engagements

"Top Market Movers: Positive News Full Access: $HSDT 2.21$ 14.51% 2026-02-13T14:00:00.000Z Solana Company (NASDAQ: HSDT) Becomes First Digital Asset Treasury to Enable Borrowing Against Natively Staked SOL in Qualified Custod https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-16T15:45Z [----] followers, [--] engagements

"Top Market Movers: Negative News Full Access: $INTS 0.25$ -32.58% 2026-02-13T13:58:00.000Z Intensity Therapeutics Announces Reverse Stock Split https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-16T15:45Z [----] followers, [--] engagements

"Latest catalysts: $VNDA Catalyst Date - 2026-02-21 Drug - Bysanti Treatment - Bipolar I disorder Schizophrenia Poa : 75% https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-02-16T15:45Z [----] followers, [--] engagements

"$OGEN 0.67$ -8.70% 2026-02-09T13:30:00.000Z Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy"
X Link 2026-02-09T15:45Z [----] followers, [--] engagements

"Latest catalysts: $MAZE Catalyst Date - 2026-02-11 Drug - MZE829 (dual-mechanism APOL1 inhibitor) Treatment - APOL1-mediated kidney disease (AMKD) Poa : 15% https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-02-10T15:45Z [----] followers, [---] engagements

"Latest catalysts: $ETON Catalyst Date - 2026-02-25 Drug - ET-600 (desmopressin oral solution) Treatment - central diabetes insipidus Poa : 85% https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-02-13T15:45Z [----] followers, [---] engagements

"Top Market Movers: Positive News Full Access: $CLRB 3.80$ 23.38% 2026-01-09T13:05:00.000Z Cellectar Biosciences to Highlight Strategic Initiatives for [----] at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-01-13T05:43Z [----] followers, [---] engagements

"$ALGS 8.45$ 5.49% 2026-01-21T13:00:00.000Z Aligos Therapeutics Provides Phase [--] B-SUPREME Study Progress Updates"
X Link 2026-01-21T15:45Z [----] followers, [---] engagements

"$SRPT 23.75$ 12.42% 2026-01-26T05:00:00.000Z Sarepta Therapeutics to Report 3-Year Topline Data from EMBARK Study of ELEVIDYS Gene Therapy in Ambulatory Individuals with Duchenne Muscular Dystrophy"
X Link 2026-01-26T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $CALC - 637.8K - 16.6M - [-----] $JUNS - 404.6K - 9.7M - [-----] $GRI - 531.9K - 10.9M - [-----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-01-28T15:45Z [----] followers, [---] engagements

"$HSCS 3.35$ 2.45% 2026-01-29T13:30:00.000Z Cibolo Health Designates HeartSciences MyoVista Insights as Endorsed ECG Management Platform for Network of [---] Independent Hospitals"
X Link 2026-01-29T15:45Z [----] followers, [--] engagements

"Top Market Movers: Negative News Full Access: $PHAR 17.30$ -15.49% 2026-02-02T05:00:00.000Z Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja (leniolisib) in children aged [--] to [--] years with https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-02T15:45Z [----] followers, [---] engagements

"$PACB 2.15$ -5.09% 2026-02-02T14:05:00.000Z PacBio Completes Sale of Short-Read Sequencing Assets"
X Link 2026-02-02T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $EVGN - 339.8K - 8.9M - [-----] $BDRX - 478.6K - 3.0M - [----] $PRTC - 3.1K - 12.6K - [----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-04T15:45Z [----] followers, [---] engagements

"Top Market Movers: Negative News Full Access: $CLGN 0.95$ -40.99% 2026-02-05T13:00:00.000Z COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-05T15:45Z [----] followers, [---] engagements

"$BLTE Catalyst Date - 2026-02-06 Drug - Tinlarebant (a/k/a LBS-008) Treatment - Stargardt disease type [--] (STGD1) Poa : 45% https://www.biopharmawatch.com/company/BLTE https://www.biopharmawatch.com/company/BLTE"
X Link 2026-02-05T15:45Z [----] followers, [--] engagements

"$HSCS 2.81$ -4.09% 2026-02-05T13:30:00.000Z University of West England Adopts HeartSciences MyoVista Insights Platform and MyoVista wavECG Device to Establish ECG Education and Technology Reference Center"
X Link 2026-02-05T15:45Z [----] followers, [---] engagements

"$ENTX 1.13$ 8.85% 2026-02-09T13:50:00.000Z Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones"
X Link 2026-02-09T15:45Z [----] followers, [--] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $BGMS - 122.7K - 2.5M - [-----] $MSLE - 6.9K - 105.0K - [-----] $PLSE - 262.3K - 2.8M - [-----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-09T15:45Z [----] followers, [---] engagements

"$OCGN 1.37$ 3.28% 2026-02-09T12:02:00.000Z Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer"
X Link 2026-02-09T15:45Z [----] followers, [---] engagements

"If you're eyeing these tickers $VOR $DBVT $TNGX $CELC $UPB $PVLA $PRME $NMRA $PHAT $CDTX $CMPX $SLDB $AVTX $SGMT $TNYA $KALA $YMAB $COGT $IRWD $KOD do your due diligence. Past performance isn't indicative of future results and biotech risks are real (think regulatory hurdles or trial failures). Our Q3 [----] update refines this further incorporating mid-year shifts like new fund inflows and evolving clinical data. Hi @Maximus_Holla @boudin420 @monaco_biotech would love to have your feedback on this Here is a full version: https://www.biopharmawatch.com/bpw-portfolio"
X Link 2026-02-09T20:52Z [----] followers, [---] engagements

"$COYA 5.15$ 5.10% 2026-02-10T13:00:00.000Z Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development Patient Landscape and Ongoing Clinical Trial"
X Link 2026-02-10T15:45Z [----] followers, [--] engagements

"$INCY 102.19$ -6.27% 2026-02-10T12:00:00.000Z Incyte Reports Fourth Quarter and Full Year [----] Financial Results"
X Link 2026-02-10T15:45Z [----] followers, [--] engagements

"Top Market Movers: Positive News Full Access: $COCH 0.48$ 21.98% 2026-02-11T05:00:00.000Z Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-11T15:45Z [----] followers, [---] engagements

"Top Market Movers: Negative News Full Access: $ATOS 4.35$ -9.75% 2026-02-11T13:30:00.000Z Atossa Therapeutics Issues Letter to Shareholders Highlighting [----] Accomplishments and [----] Outlook https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-11T15:45Z [----] followers, [---] engagements

"Highest Volume Ticker - Price - Volume $BONS - 0.00$ - $PTPI - 0.07$ - 266.5M $QNCX - 0.80$ - 254.9M $OCEA - 0.02$ - 171.4M $SRXH - 0.15$ - 90.5M https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-11T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $GLTO - 69.5K - 1.0M - [-----] $ELAB - 1.7M - 22.5M - [-----] $PRFX - 976.1K - 9.7M - [----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-11T15:45Z [----] followers, [---] engagements

"$CADL 5.44$ -5.56% 2026-02-11T13:05:00.000Z Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit"
X Link 2026-02-11T15:45Z [----] followers, [--] engagements

"Top Market Movers: Positive News Full Access: $MENS 1.73$ 18.49% 2026-02-12T13:30:00.000Z Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therap https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-12T15:45Z [----] followers, [---] engagements

"$BNTC 11.18$ -4.08% 2026-02-12T13:30:00.000Z Benitec Biopharma Releases Second Quarter [----] Financial Results and Provides Operational Update"
X Link 2026-02-12T15:45Z [----] followers, [--] engagements

"Highest Volume Ticker - Price - Volume $SANM - 77.51$ - $BONS - 0.00$ - $HLF - 8.46$ - $SCNX - 7.54$ - $PTPI - 0.07$ - 266.5M https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-12T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $PMI - 1.1M - 29.2M - [-----] $VTAK - 67.8K - 1.3M - [-----] $ONCO - 286.3K - 4.8M - [-----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-12T15:45Z [----] followers, [---] engagements

"$PMI 1.83$ 13.67% 2026-02-12T13:30:00.000Z Picard Medical/ SynCardia Highlights Successful Bridge-to-Transplant Case at UCSF Health Using the SynCardia Total Artificial Heart"
X Link 2026-02-12T15:45Z [----] followers, [--] engagements

"$BIVI 1.12$ -2.33% 2026-02-12T13:00:00.000Z BioVie Announces Abstracts Accepted for Presentation at the [----] American College of Psychiatrists Annual Meeting"
X Link 2026-02-12T15:45Z [----] followers, [--] engagements

"Top Market Movers: Positive News Full Access: $IMUX 1.11$ 28.15% 2026-02-13T11:30:00.000Z Immunic Announces Oversubscribed Private Placement of up to USD [---] Million to Accelerate Transformation into Commercial-Stage Company https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-13T15:45Z [----] followers, [---] engagements

"Top Market Movers: Negative News Full Access: $PMI 1.38$ -13.21% 2026-02-12T13:30:00.000Z Picard Medical/ SynCardia Highlights Successful Bridge-to-Transplant Case at UCSF Health Using the SynCardia Total Artificial Heart https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-13T15:45Z [----] followers, [---] engagements

"Highest Volume Ticker - Price - Volume $BONS - 0.00$ - $PTPI - 0.07$ - 266.5M $OCEA - 0.02$ - 171.4M $QNCX - 0.25$ - 88.4M $SRXH - 0.15$ - 80.7M https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-13T15:45Z [----] followers, [---] engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $PMI - 1.3M - 34.8M - [-----] $BRTX - 631.4K - 14.7M - [-----] $VTAK - 77.5K - 1.6M - [-----] https://biopharmawatch.com/market-movers https://biopharmawatch.com/market-movers"
X Link 2026-02-13T15:45Z [----] followers, [---] engagements

"$VRTX 489.47$ 5.26% 2026-02-13T00:00:00.000Z All Eyes On Vertexs Kidney Franchise as Painkiller Journavx Tops Half a Million Scripts"
X Link 2026-02-13T15:45Z [----] followers, [--] engagements

"Top [--] stocks by hedge fund holders $RCKT [--] hedge funds $RYTM [--] hedge funds $RLAY [--] hedge funds $OCUL [--] hedge funds $ASND [--] hedge funds Top [--] stocks by insider buying (net positive) $ALMS +49.50M $ATAI +19.00M $XOMA +2.50M $TARA +63.80K $GOSS +50.02K"
X Link 2026-02-13T16:07Z [----] followers, [---] engagements

"$HCWB 0.65$ -21.23% 2026-02-13T13:30:00.000Z HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune"
X Link 2026-02-16T15:45Z [----] followers, [--] engagements

"Latest catalysts: $XCUR Catalyst Date - 2026-02-05 Drug - Burixafor (GPC-100) Treatment - Multiple myeloma Poa : 68% https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-02-04T15:45Z [----] followers, [---] engagements

"Latest catalysts: $INAB Catalyst Date - 2026-02-12 Drug - DeltEx Drug Resistant Immunotherapy (DRI) Treatment - Newly diagnosed glioblastoma Poa : 18% https://biopharmawatch.com/fda-calendar https://biopharmawatch.com/fda-calendar"
X Link 2026-02-12T15:45Z [----] followers, [---] engagements

"$ASND Catalyst Date - 2026-02-28 Drug - TransCon CNP (navepegritide) Treatment - Achondroplasia Poa : 85% https://www.biopharmawatch.com/company/ASND https://www.biopharmawatch.com/company/ASND"
X Link 2026-02-13T15:45Z [----] followers, [---] engagements

"Gilead Sciences $GILD experienced its largest decline in stock value in the past ten years"
X Link 2024-01-23T08:55Z [----] followers, [---] engagements

"@monaco_biotech Also many insiders got into that wave.right before the DEERFIELD"
X Link 2024-02-26T22:33Z [----] followers, [--] engagements

"Our Top [--] BioPharma Picks from Q2 Bio Hedge Funds Data 👇 $INSM $MRUS $PCVX $EWTX $DYN $GPCR $IMVT $VRDN $XENE $CYTK Return from August [--] 2024: +11.41% Last [--] Month: +12.63% Last [--] Year: +111.97% 🚀 You can follow them at: https://biopharmawatch.com/allstockshold https://biopharmawatch.com/allstockshold"
X Link 2024-10-08T20:47Z [----] followers, [----] engagements

"Biotech Stock Catalyst Watchlist for Q1 [----] Probability of approval score card is below $ETON PDUFA $OCUL Phase [--] $TARA Phase [--] $REGN BLA $ASND PDUFA $XOMA Phase [--] $GOSS Phase [--] $CAPR BLA $RLAY Phase 1/2 $RYTM PDUFA $TELO Pre-clinical $RCKT PDUFA $LNTH PDUFA $ABVX Phase [--] $ALMS Phase [--] $MGX Preclinical $CTNM Phase 1b $SXTP Phase [--] $NAYA Phase 1/2a $ACAD Phase [--] https://twitter.com/i/web/status/2022341817685975187 https://twitter.com/i/web/status/2022341817685975187"
X Link 2026-02-13T16:07Z [----] followers, [----] engagements

"$ACXP 1.97$ 3.68% 2026-02-16T13:01:00.000Z Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter [----] Financial Results on March [--] [----] Conference Call and Provide Business Update"
X Link 2026-02-16T15:45Z [----] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing